NDC 42543-889

Efavirenz

Efavirenz

Efavirenz is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Strides Pharma Inc.. The primary component is Efavirenz.

Product ID42543-889_1254faaa-524b-4a02-9747-c813842320a3
NDC42543-889
Product TypeHuman Prescription Drug
Proprietary NameEfavirenz
Generic NameEfavirenz
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2020-12-14
Marketing CategoryANDA /
Application NumberANDA204869
Labeler NameStrides Pharma Inc.
Substance NameEFAVIRENZ
Active Ingredient Strength600 mg/1
Pharm ClassesHuman Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Non-Nucleoside Analog [EXT],Non-Nucleoside Reverse Transcriptase Inhibitors [MoA],Cytochrome P450 3A Inducers [MoA],Cytochrome P450 2B6 Inducers [MoA],Cytochrome P450 2C9 Inhibitors [MoA],Cytochrome P450 2C19 Inhibitors [MoA],Cytochrome P450 3A4 Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 42543-889-04

30 TABLET in 1 BOTTLE (42543-889-04)
Marketing Start Date2020-12-14
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Efavirenz" or generic name "Efavirenz"

NDCBrand NameGeneric Name
0378-2233Efavirenzefavirenz
31722-504EfavirenzEfavirenz
42543-889EfavirenzEfavirenz
64380-889EfavirenzEfavirenz
64980-406EfavirenzEfavirenz
64980-407EfavirenzEfavirenz
65862-049EfavirenzEfavirenz
65862-104EfavirenzEfavirenz
65862-105EfavirenzEfavirenz
65862-106EfavirenzEfavirenz
65862-774EfavirenzEfavirenz
69097-301EfavirenzEfavirenz
70518-1013Efavirenzefavirenz
70518-1100EfavirenzEfavirenz
0056-0470SUSTIVAEfavirenz
0056-0474SUSTIVAefavirenz
0056-0510SUSTIVAefavirenz
70518-0482SUSTIVAefavirenz

© 2021 FDA.report
This site is not affiliated with or endorsed by the FDA.